B

Baroness Merron (Lab)

Speaking in the House of Lords on 22 October 2026

Debate

Hormone Replacement Therapy: Product Shortage

Contribution

Inequity of access is not acceptable, but I know that it exists in all sorts of ways. We are improving the evidence base so that we can address those inequalities. As I said earlier, I am looking forward to the research on socioeconomic and ethnic disparities—but also important is, for example, the action we have taken to make HRT more affordable and to improve its availability to those who do not have to pay.

More from Baroness Merron (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.